These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26328941)

  • 41. Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
    Bittner MI; Wiedenmann N; Bucher S; Hentschel M; Mix M; Rücker G; Weber WA; Meyer PT; Werner M; Grosu AL; Kayser G
    Acta Oncol; 2016 Nov; 55(11):1299-1304. PubMed ID: 27593107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
    Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
    AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
    Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
    Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
    AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
    Thomas J; Primeaux T
    Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Wang HM; Cheng NM; Lee LY; Fang YH; Chang JT; Tsan DL; Ng SH; Liao CT; Yang LY; Yen TC
    Int J Cancer; 2016 Feb; 138(3):731-8. PubMed ID: 26311121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
    Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fructose 1,6-Bisphosphatase 1 Expression Reduces
    Chen R; Zhou X; Huang G; Liu J
    Contrast Media Mol Imaging; 2019; 2019():9463926. PubMed ID: 30723389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
    J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.
    Khandani AH; Dunphy CH; Meteesatien P; Dufault DL; Ivanovic M; Shea TC
    Nucl Med Commun; 2009 Aug; 30(8):594-601. PubMed ID: 19536037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The testing strategy for detection of biologically relevant infection of human papillomavirus in head and neck tumors for routine pathological analysis].
    Kašpírková J; Ondič O; Cerná K; Skálová A
    Cesk Patol; 2013 Jan; 49(1):29-34. PubMed ID: 23432073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
    Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H
    Oncology; 2009; 76(4):286-92. PubMed ID: 19262068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiomic Profiling of Head and Neck Cancer:
    Feliciani G; Fioroni F; Grassi E; Bertolini M; Rosca A; Timon G; Galaverni M; Iotti C; Versari A; Iori M; Ciammella P
    Contrast Media Mol Imaging; 2018; 2018():3574310. PubMed ID: 30363632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer.
    Kim BH; Chang JH
    Sci Rep; 2019 Sep; 9(1):13301. PubMed ID: 31527827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.
    Su Y; Cui J; Xu D; Wang M; Xu T; Tian H; Han F
    Crit Rev Oncol Hematol; 2018 Apr; 124():11-20. PubMed ID: 29548481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
    Bădulescu F; Bădulescu A; Crişan A; Popescu FC
    Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.